CLINICAL EFFICACY OF PELARGONIUM SIDOIDES EPS® 7630 IN COMPLEX THERAPY OF CHILDREN WITH CHRONIC ADENOIDITIS, WHO HAS UNDERGONE ADENOIDECTOMY
https://doi.org/10.21518/2079-701X-2017-16-28-32
Abstract
200 children aged 4 to 12 years diagnosed with grade 3 adenoids, chronic adenoiditis, admitted for routine surgical intervention – adenoidectomy, have been examined and treated in the Pediatric ENT-pathology Department of the Moscow Department of Health L.I. Sverzhevskiy Otorhinolaryngology Healthcare Research Institute.
2 groups of patients were formed depending on the treatment performed in the postoperative period. Group I (active treatment): 100 children who underwent conservative treatment after adenoidectomy, including: tested/investigational drug – Umckalor solution (per os), dosing regimen: children aged from 4 to 6 years – 5–10 drops 3 times a day, aged from 6 to 12 years – 10 to 20 drops 3 times a day; topical decongestants (in the age-related dosage); silver proteinate (nasal drops in age-specific doses); secondand third-generation antihistamines (in the age-specific doses). Group II (control): 100 children, who received conservative therapy after adenoidectomy, including: antibacterial therapy (in the age-specific doses) (third-generation cephalosporins); topical decongestants (in the age-specific doses); silver proteinate (nasal drops in age-specific doses); secondand third-generation antihistamines (in the age-specific doses). In both groups, the course of postoperative therapy amounted to 7 days. The clinical studies have shown that in the early postoperative period the clinical efficacy of Umckalor as part of combined therapy in children, who underwent adenoidectomy, involves reducing the duration of reactive events, accelerating the healing of the postoperative nasopharynx wound. The combined antiviral, antibacterial, immunomodulatory, anti-inflammatory, mucolytic and secretory-motor effect of the drug allows Umckalor to be used as an alternative to antibacterial drugs as part of combined therapy in children who underwent adenoidectomy.About the Authors
A. I. Kryukov
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare; Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD, Prof.
N. L. Kunelskaya
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare; Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD, Prof.
A. Yu. Ivoilov
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare; Pirogov Russian National Research Medical University Н.И. of the Ministry of Health of Russia
Russian Federation
MD
Russian Federation
MD
G. N. Izotova
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
PhD in biology
Russian Federation
PhD in biology
Yu. V. Luchsheva
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
Russian Federation
PhD in medicine
A. I. Machulin
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
Russian Federation
PhD in medicine
V. V. Yanovsky
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
I. I. Arkhangelskaya
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
V. P. Pakina
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
Russian Federation
PhD in medicine
Z. N. Morozova
Sverzhevskiy Otorhinolaryngology Healthcare Research Institute, Moscow Department of Healthcare
Russian Federation
Russian Federation
References
1. Ильенко Л.И., Парфенова А.О., Сырьева Т.Н., Гаращенко Т.И. Опыт применения препарата Умкалор при заболеваниях ЛОР-органов у детей. Педиатрическая фармакология, 2007, 5: 36-38.
2. Чучалин А.Г., Берман Б., Лемахер В. Лечение острого бронхита у взрослых экстрактом пеларгонии сидовидной (Pelargonium sidoides) (EPs® 7630): рандомизированное двойное слепое плацебо-контролируемое исследование. Пульмонология, 2007, 6: 49-55.
3. Bereznoy V, Riley D, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group Abeta-hemolytis Streptococcus tonsillopharygits ; a randomized, double-blind, placebocontrolled trial. Alternative Therapies, 2003, 9(5): 68-79.
4. Daschner F, Bachert C. Press Conference : Common cold today – chronic sinusitis tomorrow? Forschung und Praxis, Aerzte-Zeitung, 2005, 24/417: 14-15.
5. Heger M. Efficacy and safety of an extract of Pelargonium sidoides in the Treatment of the Common Cold. A multicenter, double-blind, placebo-controlled trial. Poster presentation, First International Conference on Natural Products and Molecular Therapy, Cape Town, South Africa, 2005.
6. Matthys H, Eisebitt R, Seith B, Heger M. Efficacy and safety of an extract of Pelargonium sidoides (EPs® 7630) in adults with acute bronchitis. Phytomedicine, 2003, 10(Suppl. IV): 7-17.
Review
For citations:
Kryukov AI, Kunelskaya NL, Ivoilov AY, Izotova GN, Luchsheva YV, Machulin AI, Yanovsky VV, Arkhangelskaya II, Pakina VP, Morozova ZN. CLINICAL EFFICACY OF PELARGONIUM SIDOIDES EPS® 7630 IN COMPLEX THERAPY OF CHILDREN WITH CHRONIC ADENOIDITIS, WHO HAS UNDERGONE ADENOIDECTOMY. Meditsinskiy sovet = Medical Council. 2017;(16):28-32. (In Russ.) https://doi.org/10.21518/2079-701X-2017-16-28-32
Views:
1420
Email this article 